May 19, 2020 / 3:26 PM / 11 days ago

BRIEF-Cspc Pharmaceutical Says "Docetaxel For Injection (Albumin-Bound)" Got Nod To Conduct Clinical Trials In China

May 19 (Reuters) - CSPC Pharmaceutical Group Ltd:

* CSPC PHARMACEUTICAL-“DOCETAXEL FOR INJECTION (ALBUMIN-BOUND)” DEVELOPED BY UNIT GOT APPOVAL GRANTED BY NMPA OF PRC TO CONDUCT CLINICAL TRIALS IN CHINA Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below